California News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California News Observer.

Press releases published on September 1, 2026

Sep. 1, 2026

Deadline Alert: Pentair plc (PNR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Indeterminate GlobeNewswire

Sep. 1, 2026

Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field

Indeterminate GlobeNewswire

Sep. 1, 2026

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Tarsus to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

California Resources Corporation Completes Acquisition of Crimson

Indeterminate GlobeNewswire

Sep. 1, 2026

Deadline Alert: Alarum Technologies, Ltd. (ALAR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Indeterminate GlobeNewswire

Sep. 1, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Newsweek Names California Water Service Group One of “America’s Greatest Companies”

Indeterminate GlobeNewswire

Sep. 1, 2026

Five Reputable Battery Energy Storage System Suppliers in China 2026: Advancing Energy Storage Solutions

Indeterminate EIN Presswire

Sep. 1, 2026

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Indeterminate GlobeNewswire

Sep. 1, 2026

Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 1, 2026

Cytek Biosciences to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Ultragenyx Announces the Publication of a Successful 96-Week Randomized, Placebo-Controlled Trial with Crossover Treatment of GENGLYCOS™ (also known as DTX401) AAV Gene Therapy in GSDIa in The Journal of Inherited Metabolic Disease

Indeterminate GlobeNewswire

Sep. 1, 2026

Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Astera Labs to Participate in the Citi 2026 Global TMT Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 1, 2026

BBOT to Participate in Upcoming Investor Healthcare Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 1, 2026

Deadline Alert: Aardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Indeterminate GlobeNewswire